Aug 19, 2026 08:40AM
Jul 15, 2026 06:40PM
Jul 15, 2026 06:40PM
Jun 26, 2026 04:16PM
Jun 26, 2026 04:15PM
Sep 19, 2025 05:00PM
Sep 19, 2025 05:00PM Revive Therapeutics Announces Closing of Second Tranche of Private Placement
Sep 5, 2025 07:51PM
Sep 5, 2025 07:50PM
Aug 11, 2025 07:28PM
Aug 11, 2025 07:28PM
Jul 30, 2025 08:21PM
Mar 3, 2025 08:00AM
Feb 26, 2024 04:05PM Revive Therapeutics Ltd. Announces Closing of the Second and Final Tranche of Its Private Placement for Gross Proceeds of $1,187,110
Jan 31, 2024 05:06PM
Jan 24, 2024 05:55PM
Dec 20, 2023 12:54PM
May 2, 2023 06:00AM
Apr 18, 2023 06:44PM
Mar 28, 2023 07:00AM
Mar 20, 2023 08:28AM Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
Mar 8, 2023 07:45AM
Feb 6, 2023 08:00AM
Feb 6, 2023 08:00AM
Feb 3, 2023 06:00AM
Jan 19, 2023 04:50PM
Jan 12, 2023 01:14PM
Jan 12, 2023 06:00AM Revive Therapeutics Ltd. Closes $4.3 Million Offering
Jan 9, 2023 03:34PM
Jan 5, 2023 09:19AM
Dec 22, 2022 02:00PM
Dec 15, 2022 07:29AM
Nov 30, 2022 05:43PM
Nov 24, 2022 09:18AM
Nov 22, 2022 09:20AM Revive Therapeutics Announces FDA Recommendation for Type C Meeting to Discuss Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
Oct 14, 2022 01:34PM
Oct 6, 2022 10:18AM
Sep 28, 2022 07:00AM
Sep 16, 2022 06:00AM
Sep 14, 2022 06:00AM
Aug 16, 2022 06:00AM
Jul 25, 2022 10:57AM Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
Jun 24, 2022 11:41AM
Jun 6, 2022 01:54PM
May 31, 2022 07:00AM
May 26, 2022 10:15AM
May 16, 2022 10:48AM
Apr 25, 2022 04:42PM
Apr 18, 2022 09:43AM Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19
Apr 11, 2022 05:54PM

1,188,203 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All